TY - JOUR
T1 - Development of an international, multidisciplinary, patient-centered Standard Outcome Set for Multiple Sclerosis
T2 - The S.O.S.MS project
AU - (S.O.S.MS Consensus Group)
AU - Daniels, K.
AU - Frequin, S. T.F.M.
AU - van de Garde, E. M.W.
AU - Biesma, D. H.
AU - van der Wees, P. J.
AU - van der Nat, P. B.
AU - Huseyinsinoglu, Burcu Ersoz
AU - Ben-Zacharia, Aliza Bitton
AU - Cohen, E. T.
AU - Gonçalves, Paulo Jorge Correia
AU - Kragt, J. Jolijn
AU - Hynes, Sinéad M.
AU - Marron, Frances Elizabeth
N1 - Publisher Copyright:
© 2022 The Author(s)
PY - 2023/1
Y1 - 2023/1
N2 - Background: Currently, outcomes of Multiple Sclerosis (MS) are not standardized and it is unclear which outcomes matter most to people living with MS. A consensus between patients and healthcare professionals on which outcomes to measure and how, would facilitate a move towards value-based MS care. Objective: to develop an internationally accepted, patient-relevant Standard Outcome Set for MS (S.O.S.MS). Methods: A mixed-method design was used, including a systematic literature review, four patient focus groups (n=30) and a RAND-modified Delphi process with seventeen MS experts of five disciplines from seven countries (the Netherlands, United States of America, Portugal, Ireland, India, New Zealand, Switzerland and Turkey). Results: A standard outcome set for MS was defined, consisting of fourteen outcomes divided in four domains: disease activity (n=3), symptoms (n=4), functional status (n=6), and quality of life (n=1). For each outcome, an outcome measure was selected and the measurement protocol was defined. In addition, seven case-mix variables were selected. Conclusion: This standard outcome set provides a guideline for measuring outcomes of MS in clinical practice and research. Using this set to monitor and (inter)nationally benchmark real-world outcomes of MS can support improvement of patient value and ultimately guide the transition towards value-based MS care.
AB - Background: Currently, outcomes of Multiple Sclerosis (MS) are not standardized and it is unclear which outcomes matter most to people living with MS. A consensus between patients and healthcare professionals on which outcomes to measure and how, would facilitate a move towards value-based MS care. Objective: to develop an internationally accepted, patient-relevant Standard Outcome Set for MS (S.O.S.MS). Methods: A mixed-method design was used, including a systematic literature review, four patient focus groups (n=30) and a RAND-modified Delphi process with seventeen MS experts of five disciplines from seven countries (the Netherlands, United States of America, Portugal, Ireland, India, New Zealand, Switzerland and Turkey). Results: A standard outcome set for MS was defined, consisting of fourteen outcomes divided in four domains: disease activity (n=3), symptoms (n=4), functional status (n=6), and quality of life (n=1). For each outcome, an outcome measure was selected and the measurement protocol was defined. In addition, seven case-mix variables were selected. Conclusion: This standard outcome set provides a guideline for measuring outcomes of MS in clinical practice and research. Using this set to monitor and (inter)nationally benchmark real-world outcomes of MS can support improvement of patient value and ultimately guide the transition towards value-based MS care.
KW - Benchmark
KW - Core outcomes
KW - Multiple sclerosis
KW - Outcome indicator
KW - Outcome set
KW - PROM
KW - Patient-reported outcomes
KW - Value-based healthcare
UR - http://www.scopus.com/inward/record.url?scp=85144503759&partnerID=8YFLogxK
U2 - 10.1016/j.msard.2022.104461
DO - 10.1016/j.msard.2022.104461
M3 - Article
AN - SCOPUS:85144503759
SN - 2211-0348
VL - 69
JO - Multiple Sclerosis and Related Disorders
JF - Multiple Sclerosis and Related Disorders
M1 - 104461
ER -